These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22487225)

  • 21. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
    Gerstenfeld EP
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1000-1. PubMed ID: 20487115
    [No Abstract]   [Full Text] [Related]  

  • 22. Underdetection of Ventricular Fibrillation by Wearable Cardioverter-Defibrillator Leading to Sudden Death.
    Kokubun H; Miyauchi Y; Inada S; Shimizu W
    Circ J; 2020 Dec; 85(1):79. PubMed ID: 33208580
    [No Abstract]   [Full Text] [Related]  

  • 23. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
    Volosin KJ; Exner DV; Wathen MS; Sherfesee L; Scinicariello AP; Gillberg JM
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):280-9. PubMed ID: 20958831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Sweeney MO
    Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472
    [No Abstract]   [Full Text] [Related]  

  • 26. Alcohol-induced ventricular fibrillation in a case of Brugada syndrome.
    Ohkubo K; Nakai T; Watanabe I
    Europace; 2013 Jul; 15(7):1058. PubMed ID: 23365071
    [No Abstract]   [Full Text] [Related]  

  • 27. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome.
    Takigawa M; Noda T; Shimizu W; Miyamoto K; Okamura H; Satomi K; Suyama K; Aihara N; Kamakura S; Kurita T
    Heart Rhythm; 2008 Nov; 5(11):1523-7. PubMed ID: 18984526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annual distribution of ventricular tachycardias and ventricular fibrillation.
    Müller D; Lampe F; Wegscheider K; Schultheiss HP; Behrens S
    Am Heart J; 2003 Dec; 146(6):1061-5. PubMed ID: 14660999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Between an ICD and a hard place.
    Deyell MW; Callans DJ
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1120-2. PubMed ID: 21635613
    [No Abstract]   [Full Text] [Related]  

  • 30. Brugada syndrome and syncope: a practical approach for diagnosis and treatment.
    Mascia G; Bona RD; Ameri P; Canepa M; Porto I; Parati G; Crotti L; Brignole M
    Europace; 2021 Jul; 23(7):996-1002. PubMed ID: 33367713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of implantable cardiac defibrillators in cardiac sarcoidosis: saviour or sinner?
    Heck PM; Roberts PR
    Europace; 2013 Mar; 15(3):309-10. PubMed ID: 23355135
    [No Abstract]   [Full Text] [Related]  

  • 32. Brugada syndrome: Diagnosis, risk stratification and management.
    Gourraud JB; Barc J; Thollet A; Le Marec H; Probst V
    Arch Cardiovasc Dis; 2017 Mar; 110(3):188-195. PubMed ID: 28139454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond the implantable cardioverter-defibrillator: are we making progress?
    Weiss JN
    Heart Rhythm; 2008 Jun; 5(6 Suppl):S45-7. PubMed ID: 18456201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exaggerated Reactivity of Parasympathetic Nerves Is Involved in Ventricular Fibrillation in J-Wave Syndrome.
    Shinohara T; Kondo H; Otsubo T; Fukui A; Yufu K; Nakagawa M; Takahashi N
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):321-326. PubMed ID: 27885745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal Sympathetic Denervation for the Treatment of Ventricular Arrhythmias: A Lesson in Not Throwing Out the Baby With the Bathwater?
    Reddy VY; Miller MA
    JACC Cardiovasc Interv; 2015 Jun; 8(7):991-3. PubMed ID: 26088517
    [No Abstract]   [Full Text] [Related]  

  • 36. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Khairy P
    Heart; 2016 Nov; 102(21):1703-1709. PubMed ID: 27250216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of ventricular arrhythmias in suspected channelopathies.
    Obeyesekere MN; Antzelevitch C; Krahn AD
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):221-31. PubMed ID: 25691556
    [No Abstract]   [Full Text] [Related]  

  • 39. MY APPROACH to early repolarization syndrome.
    Yan GX
    Trends Cardiovasc Med; 2016 May; 26(4):393-4. PubMed ID: 26944231
    [No Abstract]   [Full Text] [Related]  

  • 40. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.